MPAA
Motorcar Parts of America, Inc.
MPAA has slightly lower modeled downside risk, despite its lower overall score.
RIVN
Rivian Automotive, Inc.
RIVN has the edge over MPAA overall, supported by stronger fundamentals and stronger modeled upside.
MPAA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Under pressure |
MPAA's revenue, profitability, cash flow and balance sheet are all currently under pressure.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MPAA PE Valuation
MPAA has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
MPAA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect MPAA's earnings to grow and its profitability to improve, with its revenue holding steady.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over MPAA on the outlook, with more favorable revenue expectations.
MPAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | — |
| Q3 2026 | -$0.16 | -233% |
| Q2 2026 | -$0.24 | -400% |
| Q1 2026 | $0.62 | +$1.61 |
| Q4 2025 | $0.10 | +$1.00 |
| Q3 2025 | $0.12 | +$3.53 |
| Q2 2025 | $0.08 | +$3.44 |
| Q1 2025 | -$0.99 | +$1.52 |
| Q4 2024 | -$0.90 | +$1.59 |
MPAA has swung to a loss: it lost $0.16 per share over the past year, after a profit the year before.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over MPAA on earnings, with more consistent year-over-year improvement.
MPAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $169.2M | -24% |
| Q2 2026 | $168M | -11% |
| Q1 2026 | $212.3M | +9.9% |
| Q4 2025 | $167.7M | -9.9% |
| Q3 2025 | $221.5M | +6.4% |
| Q2 2025 | $188.4M | +11% |
| Q1 2025 | $193.1M | +1.9% |
| Q4 2024 | $186.2M | +8.3% |
MPAA's revenue has slid since its 2025 peak: $169M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.9% | -1.5 points |
| Q2 2026 | 2.1% | -8.6 points |
| Q1 2026 | 9.9% | +1.5 points |
| Q4 2025 | 5% | -4.5 points |
| Q3 2025 | 7.4% | +1.4 points |
| Q2 2025 | 11% | +14 points |
| Q1 2025 | 8.4% | +2 points |
| Q4 2024 | 9.4% | +3.9 points |
MPAA has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over MPAA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
MPAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.8M | -123% |
| Q2 2026 | -$12.4M | -235% |
| Q1 2026 | -$6M | -195% |
| Q4 2025 | -$8.6M | -126% |
| Q3 2025 | $20.8M | -6.5% |
| Q2 2025 | $9.2M | +$30.6M |
| Q1 2025 | $6.2M | +$16.1M |
| Q4 2024 | $33.7M | -37% |
MPAA's free cash flow was −$32M over the past year, against $70M the year before.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has the edge over MPAA on cash flow, with more consistent year-over-year improvement.
MPAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +19% | +3.6M shares |
| 1 year | +16% | +3.1M shares |
| 3 years | +15% | +2.9M shares |
| 5 years | +15% | +2.9M shares |
| Available history | +16% | +3.2M shares |
MPAA has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.9M |
| Q1 2026 | $3M |
| Q4 2025 | $5M |
| Q3 2025 | $1.4M |
| Q2 2025 | $2M |
| Q1 2025 | $2.7M |
| Q1 2023 | — |
MPAA spent $10M buying back its own shares over the past year.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
MPAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 3.5x | Elevated |
| Q1 2024 | 2.0x | Moderate |
| Q4 2023 | 1.5x | Healthy |
| Q3 2023 | 2.5x | Moderate |
| Q2 2023 | 3.1x | Elevated |
| Q1 2023 | 2.8x | Moderate |
| Q1 2020 | 3.9x | Elevated |
MPAA's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.5 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MPAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.6 | Oversold |
| Stochastic | 11.6 | Oversold |
MPAA's weekly RSI is 27 (oversold) and its Stochastic is 12 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
MPAA PE vs Consumer Cyclical Sector
| Metric | MPAA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MPAA has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
MPAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.1 | 24% below |
| 20 week MA | $11.7 | 34% below |
| 50 week MA | $11.9 | 35% below |
| 100 week MA | $11.6 | 34% below |
| 200 week MA | $9.65 | 20% below |
MPAA is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
MPAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.9 | $19.9 | -9.2% |
| 2021 | $19.9 | $16.7 | -16% |
| 2022 | $16.7 | $11.3 | -32% |
| 2023 | $11.3 | $9.34 | -17% |
| 2024 | $9.34 | $8.05 | -14% |
| 2025 | $8.05 | $12.5 | +55% |
| 2026 YTD | $12.5 | $7.71 | -38% |
MPAA has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.